SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX)
CUSIP: 85205L107
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock, par value $.0001 per share
- Shares outstanding
- 75,607,738
- Total 13F shares
- 80,867,369
- Share change
- -4,169,513
- Total reported value
- $2,921,793,248
- Put/Call ratio
- 149%
- Price per share
- $36.13
- Number of holders
- 214
- Value change
- -$118,091,155
- Number of buys
- 115
- Number of sells
- 107
Quarterly Holders Quick Answers
What is CUSIP 85205L107?
CUSIP 85205L107 identifies SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 85205L107:
Top shareholders of SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
15%
|
11,140,946
|
$356,955,910 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13D/G
13F
|
The Vanguard Group · Company |
9.6%
|
7,158,871
|
$331,026,195 | $0 | 31 Dec 2024 | |
| Stephen P. Squinto |
3/4/5
|
Director, 10%+ Owner |
—
mixed-class rows
|
6,333,277
mixed-class rows
|
$262,384,838 | — | 19 May 2022 | |
| ORBIMED ADVISORS LLC |
3/4/5
13F
|
10%+ Owner · Company |
1.8%
from 13F
|
5,599,842
|
$232,561,438 | — | 12 Sep 2022 | |
| Bain Capital Life Sciences Investors, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
4,832,413
|
$200,690,112 | — | 10 Aug 2021 | |
| BlackRock, Inc. |
13F
|
Company |
7.9%
|
5,941,797
|
$190,375,177 | — | 30 Sep 2024 | |
| Deep Track Capital, LP |
13D/G
13F
|
Company |
4.6%
|
3,460,756
|
$160,025,357 | $0 | 31 Dec 2024 | |
| Jeffrey Lawrence Schwartz |
3/4/5
|
Director |
—
mixed-class rows
|
3,105,653
mixed-class rows
|
$128,405,735 | — | 24 May 2023 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
4.7%
|
3,516,418
|
$112,667,000 | — | 30 Sep 2024 | |
| Boxer Capital, LLC |
13F
|
Company |
4.5%
|
3,421,541
|
$109,626,174 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
4.1%
|
3,090,552
|
$99,021,286 | — | 30 Sep 2024 | |
| MAVERICK CAPITAL LTD |
13F
|
Company |
3.7%
|
2,778,348
|
$89,018,270 | — | 30 Sep 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
2.6%
|
1,961,830
|
$62,857,035 | — | 30 Sep 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
2.5%
|
1,925,918
|
$61,707,910 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
1,670,247
|
$53,525,542 | — | 30 Sep 2024 | |
| Polar Capital Holdings Plc |
13F
|
Company |
2%
|
1,500,000
|
$48,060,000 | — | 30 Sep 2024 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
2%
|
1,492,062
|
$47,805,666 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.9%
|
1,438,635
|
$46,093,873 | — | 30 Sep 2024 | |
| Woodline Partners LP |
13F
|
Company |
1.8%
|
1,381,624
|
$44,267,233 | — | 30 Sep 2024 | |
| Siren, L.L.C. |
13F
|
Individual |
1.8%
|
1,377,701
|
$44,141,540 | — | 30 Sep 2024 | |
| Fiera Capital Corp |
13F
|
Company |
1.7%
|
1,257,964
|
$40,305,167 | — | 30 Sep 2024 | |
| Capital International Investors |
13F
|
Company |
1.6%
|
1,225,667
|
$39,270,371 | — | 30 Sep 2024 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
1.4%
|
1,069,738
|
$34,274,000 | — | 30 Sep 2024 | |
| GW&K Investment Management, LLC |
13F
|
Company |
1.2%
|
925,361
|
$29,648,000 | — | 30 Sep 2024 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
1.2%
|
918,445
|
$29,427,000 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.1%
|
861,210
|
$27,593,167 | — | 30 Sep 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
1.1%
|
845,170
|
$27,078,034 | — | 30 Sep 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
1.1%
|
797,877
|
$25,563,984 | — | 30 Sep 2024 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.96%
|
729,125
|
$23,361,165 | — | 30 Sep 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.96%
|
725,117
|
$23,233,279 | — | 30 Sep 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.96%
|
724,682
|
$23,218,812 | — | 30 Sep 2024 | |
| Duquesne Family Office LLC |
13F
|
Company |
0.93%
|
705,066
|
$22,590,000 | — | 30 Sep 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.92%
|
692,263
|
$22,180,107 | — | 30 Sep 2024 | |
| Finepoint Capital LP |
13F
|
Company |
0.86%
|
650,852
|
$20,853,298 | — | 30 Sep 2024 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.85%
|
643,192
|
$20,607,872 | — | 30 Sep 2024 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.83%
|
629,387
|
$20,165,559 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.8%
|
602,770
|
$19,312,751 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.8%
|
602,227
|
$19,295,353 | — | 30 Sep 2024 | |
| SOROS FUND MANAGEMENT LLC |
13F
|
Company |
0.74%
|
559,321
|
$17,920,645 | — | 30 Sep 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.69%
|
524,743
|
$16,812,765 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.56%
|
421,776
|
$13,513,703 | — | 30 Sep 2024 | |
| Cutter Capital Management, LP |
13F
|
Company |
0.5%
|
378,453
|
$12,125,634 | — | 30 Sep 2024 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.48%
|
364,060
|
$11,664,482 | — | 30 Sep 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.43%
|
322,086
|
$10,319,635 | — | 30 Sep 2024 | |
| L. Mary Smith |
3/4/5
|
Chief Development Officer |
—
mixed-class rows
|
293,363
mixed-class rows
|
$9,691,565 | — | 04 Jan 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.39%
|
297,899
|
$9,544,683 | — | 30 Sep 2024 | |
| EAGLE ASSET MANAGEMENT INC |
13F
|
Company |
0.36%
|
273,479
|
$9,295,551 | — | 30 Sep 2024 | |
| Walleye Capital LLC |
13F
|
Company |
0.38%
|
286,093
|
$9,166,420 | — | 30 Sep 2024 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.38%
|
285,555
|
$9,149,182 | — | 30 Sep 2024 | |
| Jefferies Financial Group Inc. |
13F
|
Company |
0.36%
|
275,000
|
$8,811,000 | — | 30 Sep 2024 |
Institutional Holders of SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX) as of Q4 2024
As of 31 Dec 2024,
SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX) was held by
214 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
80,867,369 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, BlackRock, Inc., Deep Track Capital, LP, Boxer Capital Management, LLC, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, MAVERICK CAPITAL LTD, Pictet Asset Management Holding SA, and Capital International Investors.
This page lists
214
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
224
Q4 2024 holders
214
Holder diff
-10
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.